Related Experiment Video
Updated: Jun 24, 2026

09:47
DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Factors influencing the statistical power of complex data analysis protocols for molecular signature development from
Constantin F Aliferis1, Alexander Statnikov, Ioannis Tsamardinos
1Center of Health Informatics and Bioinformatics, New York University, New York, New York, United States of America. constantin.aliferis@nyumc.org
Plos One
|March 18, 2009
Summary
Optimizing multivariate analysis protocols for high-throughput data significantly enhances statistical power. Careful selection of analysis components can reduce sample size requirements for molecular signature development and improve predictive accuracy.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Statistical significance and reproducibility are crucial for molecular signatures from high-throughput data.
- Current methods often rely on univariate tests, with limited understanding of multivariate analysis power.
Purpose of the Study:
- To investigate factors influencing the statistical power of multivariate analysis protocols for molecular signature development.
- To identify key components of analysis that impact power and reproducibility.
Main Methods:
- Empirical analysis of 7 large microarray cancer outcome prediction datasets.
- Supplementary simulations to assess the effects of different analysis components.
- Comparison with prior analyses of the same datasets.
Main Results:
- Specific choices in error metric, classifier, error estimator, and event balancing significantly affect statistical power.
- These effects are compounding, demonstrating a substantial impact on results.
- Prior analyses showing poor prediction accuracy were likely due to under-powered methods.
Conclusions:
- Optimizing multivariate analysis protocols can reduce sample size needs for high-throughput studies.
- Identified factors allow for more efficient and powerful molecular signature development.
- Revises previous conclusions about the limitations of microarray-based outcome prediction.

